 isradipin overal clinic experi hypertens unit isradipin new dihydropyridin calcium antagonist efficaci safe treatment hypertens patient age race evid neg inotrop atrioventricular conduct delay signific chang laboratori paramet isradipin treatment total patient isradipin double-blind hypertens trial patient placebo activ control hydrochlorothiazid enalapril mean chang baselin diastol systol blood pressur percentag patient treatment blood pressur decreas mm Hg isradipin placebo activ control blood pressur respons increas isradipin mg dose averag result blood pressur reduct incid advers reaction isradipin similar activ control placebo discontinu isradipin addit decreas incid new advers reaction durat treatment month